<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-pharmaceuticals-12-00147">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Terrier</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Carron</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>De Chassey</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Dubois</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Traversier</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Julien</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Cartet</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Proust</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hacot</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ressnikoff</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication</article-title>
  <source>Sci. Rep.</source>
  <year>2016</year>
  <volume>6</volume>
  <fpage>29006</fpage>
  <pub-id pub-id-type="doi">10.1038/srep29006</pub-id>
  <?supplied-pmid 27373907?>
  <pub-id pub-id-type="pmid">27373907</pub-id>
 </element-citation>
</ref>
